StockData
Bioxytran, Inc logo

Bioxytran, Inc (BIXT) stock

BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.02−0.00 (-3.95%)

Close on Oct 19, 2026Market cap $2.56MP/E –Yield –

Bioxytran price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Bioxytran's price to sales ratio was 304.4× on Oct 31, 2018, against 51.7× a year earlier. Over the last 3 years it ranged from 28.9× to 467.7×, with a median of 139.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2018Oct 31, 2018304.4×−33.4
2017Dec 29, 2017337.8×+260.8
2016Dec 30, 201676.9×−83.1
2015Jan 30, 2015160.0×+0.0
2014Dec 31, 2014160.0×−303.9
2013Apr 30, 2013464.0×–

More Bioxytran figures

See a number that looks wrong?